Vivos Therapeutics (VVOS) Operating Income (2020 - 2026)
Vivos Therapeutics (VVOS) reported Operating Income of -$6.6 million for Q1 2026, down 68.84% year-over-year from -$21.2 million in Q1 2025, and down 3.65% on a QoQ basis from -$6.4 million in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Operating Income data on file, last reported at -$6.6 million in Q1 2026.
- Quarterly Operating Income fell 68.84% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.6 million (down 99.88% YoY) and the FY2025 annual result came in at -$19.9 million, down 78.09% from the prior year.
- Operating Income retreated to -$6.6 million in Q1 2026 per VVOS's latest filing, from -$6.4 million in the prior quarter.
- Across five years, Operating Income topped out at -$1.9 million in Q2 2024 and bottomed at -$7.0 million in Q2 2022.
- The 5-year median for Operating Income is -$4.7 million (2025), against an average of -$4.7 million.
- The widest annual swing landed in 2022, when Operating Income slumped 169.61%; it then surged 57.14% in 2024.
- Tracing VVOS's Operating Income over 5 years: stood at -$6.1 million in 2022, then surged by 31.83% to -$4.1 million in 2023, then jumped by 32.11% to -$2.8 million in 2024, then plunged by 127.44% to -$6.4 million in 2025, then declined by 3.65% to -$6.6 million in 2026.
- Per Business Quant, the three latest VVOS Operating Income figures stand at -$6.6 million (Q1 2026), -$6.4 million (Q4 2025), and -$4.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -6.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.62 Mn |
| Dec 31, 2025 | -6.38 Mn |
| Sep 30, 2025 | -4.73 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -2.81 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -3.79 Mn |
| Dec 31, 2023 | -4.13 Mn |
| Sep 30, 2023 | -3.64 Mn |
| Jun 30, 2023 | -4.52 Mn |
| Mar 31, 2023 | -5.01 Mn |
| Dec 31, 2022 | -6.06 Mn |
| Sep 30, 2022 | -5.41 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | -6.64 Mn |
| Dec 31, 2021 | 8.71 Mn |
| Sep 30, 2021 | -5.50 Mn |
| Jun 30, 2021 | -4.06 Mn |
| Mar 31, 2021 | -3.41 Mn |
| Dec 31, 2020 | -6.25 Mn |
| Sep 30, 2020 | -1.82 Mn |
| Jun 30, 2020 | -1.42 Mn |
| Mar 31, 2020 | -2.56 Mn |